Literature DB >> 10721932

Tea and tea polyphenols in cancer prevention.

C S Yang1, J Y Chung, G Yang, S K Chhabra, M J Lee.   

Abstract

The inhibitory action of tea (Camellia sinensis) and tea components against cancer formation has been demonstrated in different animal models involving different organ sites in many laboratories. The possible preventive activity of tea against cancer in humans, however, is not clear. A critical question is whether the information obtained from animal studies is applicable to humans because of possible species differences or the difference in the quantity of tea used in animal studies and that consumed by humans. This article will discuss the results from animal studies and possible cancer inhibitory mechanisms that might be applicable to human cancer prevention. To provide a basis for more quantitative analyses of the effect of tea on carcinogenesis, the levels of tea polyphenols in blood, urine and tissue samples have been analyzed, and the pharmacokinetic properties of tea polyphenols studied. Studies with cell lines have demonstrated that tea polyphenols affect signal transduction pathways, inhibit cell proliferation and induce apoptosis, but the effective concentrations are usually much higher than those observed in blood and tissues. More mechanistic studies in these areas will help us to understand the inhibitory action of tea against carcinogenesis and provide background for evaluating the effects of tea consumption on human carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10721932     DOI: 10.1093/jn/130.2.472S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  43 in total

1.  Tea consumption and basal cell and squamous cell skin cancer: results of a case-control study.

Authors:  Judy R Rees; Therese A Stukel; Ann E Perry; Michael S Zens; Steven K Spencer; Margaret R Karagas
Journal:  J Am Acad Dermatol       Date:  2007-01-29       Impact factor: 11.527

2.  Comparison of the impact of epigallocatechin gallate and ellagic acid in an experimental cataract model induced by sodium selenite.

Authors:  Irfan Ergen; Burak Turgut; Nevin Ilhan
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

3.  Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.

Authors:  Xiaobo Zhang; Kyung-Won Min; Jay Wimalasena; Seung Joon Baek
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-20       Impact factor: 4.553

Review 4.  Molecular and cellular targets.

Authors:  Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2006-06       Impact factor: 4.784

5.  Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinoma.

Authors:  Orazio Vittorio; Giuseppe Cirillo; Francesca Iemma; Giovanni Di Turi; Emanuela Jacchetti; Michele Curcio; Serena Barbuti; Niccola Funel; Ortensia Ilaria Parisi; Francesco Puoci; Nevio Picci
Journal:  Pharm Res       Date:  2012-05-24       Impact factor: 4.200

6.  Effects of selected herb extracts on iron-catalyzed lipid oxidation in soybean oil-in-water emulsion.

Authors:  Jeongha Kim; Eunok Choe
Journal:  Food Sci Biotechnol       Date:  2016-08-31       Impact factor: 2.391

7.  Green tea catechin (-)-epicatechin gallate induces tumour suppressor protein ATF3 via EGR-1 activation.

Authors:  Kyou-Nam Cho; Mugdha Sukhthankar; Seong-Ho Lee; Joo-Heon Yoon; Seung Joon Baek
Journal:  Eur J Cancer       Date:  2007-08-30       Impact factor: 9.162

Review 8.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Chem Res Toxicol       Date:  2008-02-23       Impact factor: 3.739

10.  Increased responsiveness of human coronary artery endothelial cells in inflammation and coagulation.

Authors:  Katja Lakota; Katjusa Mrak-Poljsak; Blaz Rozman; Snezna Sodin-Semrl
Journal:  Mediators Inflamm       Date:  2010-01-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.